We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





BD Presents Latest Automated Solutions to Combat Antimicrobial Resistance at ECCMID 2022

By LabMedica International staff writers
Posted on 26 Apr 2022
Print article
Image: BD MAX system combines automating extraction and thermocycling into single platform (Photo courtesy of BD)
Image: BD MAX system combines automating extraction and thermocycling into single platform (Photo courtesy of BD)

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) presented its latest automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance at ECCMID 2022.

BD showcased its Kiestra lab automation solutions that provide total lab automation for the clinical microbiology lab through modularity, scalability and open architecture. These solutions are designed to increase efficiency, streamline processes, and deliver high quality and consistent results with improved turnaround time. BD Kiestra lab automation offerings include complementary and modular microbiology workflow automation solutions, ranging from standalone units to fully automated track-based automation systems for mid- and high-volume labs.

On display was the BD Kiestra IdentifA solution, which is available as part of a track-based BD Kiestra laboratory automation solution, and supports specimen preparation workflows for routine and challenging isolate types in combination with identification on the BD Bruker MALDI Biotyper. The BD Kiestra IdentifA solution helps bring accuracy and efficiency to preparing samples for microbial identification. By automating the sample processing steps required to identify a microorganism, this solution helps reduce potential for user error while providing clinicians with bacterial identification for a patient suspected of having an infection.

BD also demonstrated its BACTEC FX blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections. The BD BACTEC FX builds on the proven superior fluorescence detection technology, exceptional media performance and instrument reliability of the BD BACTEC 9000 blood culture systems. Also on display at the event was the BD MAX System, a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than three hours.

Related Links:
Becton, Dickinson and Company 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.